MYO | TWST | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 64 | |
SMR RATING 1..100 | 99 | 97 | |
PRICE GROWTH RATING 1..100 | 35 | 34 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MYO's Valuation (42) in the Medical Distributors industry is in the same range as TWST (69) in the Biotechnology industry. This means that MYO’s stock grew similarly to TWST’s over the last 12 months.
TWST's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for MYO (100) in the Medical Distributors industry. This means that TWST’s stock grew somewhat faster than MYO’s over the last 12 months.
TWST's SMR Rating (97) in the Biotechnology industry is in the same range as MYO (99) in the Medical Distributors industry. This means that TWST’s stock grew similarly to MYO’s over the last 12 months.
TWST's Price Growth Rating (34) in the Biotechnology industry is in the same range as MYO (35) in the Medical Distributors industry. This means that TWST’s stock grew similarly to MYO’s over the last 12 months.
TWST's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MYO (100) in the Medical Distributors industry. This means that TWST’s stock grew similarly to MYO’s over the last 12 months.
| MYO | TWST | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 90% | 1 day ago 80% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 75% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 83% |
| Advances ODDS (%) | 5 days ago 78% | 9 days ago 80% |
| Declines ODDS (%) | 17 days ago 90% | 4 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 78% | 1 day ago 87% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 78% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MYO’s FA Score shows that 0 FA rating(s) are green while TWST’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MYO’s TA Score shows that 4 TA indicator(s) are bullish while TWST’s TA Score has 4 bullish TA indicator(s).
MYO (@Medical/Nursing Services) experienced а +8.78% price change this week, while TWST (@Biotechnology) price change was +9.49% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.06%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was +1.93%.
The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.
MYO is expected to report earnings on Nov 11, 2026.
TWST is expected to report earnings on Nov 13, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Biotechnology (-4.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVDS | 79.13 | 0.57 | +0.73% |
| Avantis International Small Cap Equity ETF (AVDS) | |||
| IVOG | 138.03 | 0.14 | +0.10% |
| Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) | |||
| CVRD | 18.43 | N/A | N/A |
| Madison Covered Call ETF (CVRD) | |||
| TSYW | 39.06 | -0.06 | -0.14% |
| Roundhill Treasury Bond WeeklyPay ETF (TSYW) | |||
| LFGY | 20.09 | -0.26 | -1.28% |
| YieldMax Crypto Industry & Tech Portfolio Option Income ETF | |||
A.I.dvisor indicates that over the last year, MYO has been loosely correlated with NEO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MYO jumps, then NEO could also see price increases.
| Ticker / NAME | Correlation To MYO | 1D Price Change % | ||
|---|---|---|---|---|
| MYO | 100% | -3.59% | ||
| NEO - MYO | 33% Loosely correlated | -1.18% | ||
| PFSA - MYO | 32% Poorly correlated | -28.05% | ||
| RDNT - MYO | 31% Poorly correlated | -0.73% | ||
| TWST - MYO | 31% Poorly correlated | -0.65% | ||
| NTRA - MYO | 31% Poorly correlated | +0.92% | ||
More | ||||
A.I.dvisor indicates that over the last year, TWST has been loosely correlated with DNA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if TWST jumps, then DNA could also see price increases.
| Ticker / NAME | Correlation To TWST | 1D Price Change % | ||
|---|---|---|---|---|
| TWST | 100% | -0.65% | ||
| DNA - TWST | 55% Loosely correlated | +4.00% | ||
| RXRX - TWST | 54% Loosely correlated | -3.86% | ||
| RVTY - TWST | 53% Loosely correlated | +0.29% | ||
| ITGR - TWST | 50% Loosely correlated | +0.13% | ||
| PSNL - TWST | 50% Loosely correlated | -0.66% | ||
More | ||||